Try a new search

Format these results:

Searched for:

person:mak12

in-biosketch:yes

Total Results:

72


Routine surveillance scanning in HNSCC: Lung screening CT scans have value but head and neck scans do not

Iovoli, Austin J; Platek, Alexis J; Degraaff, Luke; Wang, Chong; Duncan, William D; Wooten, Kimberly E; Arshad, Hassan; Gupta, Vishal; Kuriakose, Moni A; Hicks, Wesley L; Platek, Mary E; Singh, Anurag K
OBJECTIVES/OBJECTIVE:To examine the utility of computed tomography (CT) imaging during routine surveillance for the detection of recurrent head and neck squamous cell carcinoma (HNSCC). MATERIALS/METHODS/METHODS:Clinical characteristics of HNSCC patients treated between 2008 and 2017 with radiation therapy or concurrent chemoradiation were abstracted from medical records. In patients who achieved a complete response to treatment by positron emission tomography scan, surveillance CT scans were conducted to the maxillofacial area, neck, and chest every 3 months in year 1, every 6 months in year 2, and every 12 months in years 3 and beyond. RESULTS:Within the entire cohort (n = 534), complete response was achieved in 446 patients (83.5%); of these, 84 (15.7%) patients had a recurrence. Among the 84 patients with disease recurrence, 25 (30%) patients remained alive, of which 15 (18%) underwent successful salvage treatment and became free of disease. Lung screening CT scans detected failure in 8 of these successfully salvaged patients. Among the 8 patients successfully salvaged for locoregional recurrence, 3 failures were asymptomatic at onset and detected by laryngoscope or dental exam. The remaining 5 failures were symptomatic and detected upon work up prompted by symptoms. Maxillofacial and neck surveillance CT imaging failed to detect any successfully salvaged patients. CONCLUSIONS:Routine surveillance for HNSCC patients with lung CT imaging had value but routine head and neck CT scans failed to identify any successfully salvaged patients. Given this finding, routine CT imaging surveillance in HNSCC patients should be restricted to annual lung screening with low-dose chest CT.
PMID: 30409312
ISSN: 1879-0593
CID: 3456242

Combined surgery and radiation improves survival of tonsil squamous cell cancers

Singh, Anurag K; Mimikos, Christina; Groman, Adrienne; Dibaj, Shiva; Platek, Alexis J; Cohan, David M; Hicks, Wesley L; Gupta, Vishal; Arshad, Hassan; Kuriakose, Moni A; Warren, Graham W; Platek, Mary E
Objective/UNASSIGNED:The study evaluated the addition of surgery (S) to radiation (RT) on survival of squamous cell carcinomas (SCC) of tonsillar-fossa (TF) in a modern cohort with similar epidemiology and treatment as current patients. Study Design/UNASSIGNED:Retrospective analysis utilizing Surveillance, Epidemiology, and End Results (SEER) Program data. Results/UNASSIGNED:< 0.001). Materials and Methods/UNASSIGNED:= 6,476). Primary outcome measures included overall survival (OS) and disease specific survival (DSS). Cox proportional hazard ratios (HR) were estimated for patients treated with S+RT compared to RT alone. Conclusions/UNASSIGNED:OS and DSS were superior for all stages combined and for stages 2, 3, and 4 in TF patients who received S+RT compared to RT alone.
PMCID:5762522
PMID: 29348837
ISSN: 1949-2553
CID: 3061192

Curcumin and metformin mediated chemoprevention of oral cancer is associated with inhibition of cancer stem cells

Siddappa, Gangotri; Kulsum, Safeena; Ravindra, Doddathimmasandra Ramanjanappa; Kumar, Vinay V; Raju, Nalini; Raghavan, Nisheena; Sudheendra, Holalugunda Vittalamurthy; Sharma, Anupam; Sunny, Sumsum P; Jacob, Tina; Kuruvilla, Binu T; Benny, Merina; Antony, Benny; Seshadri, Mukund; Lakshminarayan, Padma; Hicks, Wesley Jr; Suresh, Amritha; Kuriakose, Moni A
Effective chemoprevention is critical for improving outcomes of oral cancer. As single agents, curcumin and metformin, are reported to exhibit chemopreventive properties, in vitro as well as in patients with oral cancer. In this study, the chemopreventive efficacy of this drug combination was tested in a 4NQO (4-nitro-quinoline-oxide) induced, mice oral carcinogenesis model. Molecular analysis revealed a cancer stem cell (CSC)-driven, oral carcinogenic progression in this model, wherein a progressive increase in the expression of CSC-specific markers (CD44 and CD133) was observed from 8th to 25th week, at transcript (40 to 100 fold) and protein levels (p
PMID: 28618017
ISSN: 1098-2744
CID: 2594302

Subsite variation in survival of oropharyngeal squamous cell carcinomas 2004 to 2011

Platek, Mary E; Jayaprakash, Vijayvel; Gupta, Vishal; Cohan, David M; Hicks, Wesley L; Winslow, Timothy B; Platek, Alexis J; Groman, Adrienne; Dibaj, Shiva; Arshad, Hassan; Kuriakose, Moni A; Warren, Graham W; Singh, Anurag K
OBJECTIVES/HYPOTHESIS/OBJECTIVE:To evaluate subsite-specific differences in survival between squamous cell carcinomas of the base of tongue and tonsillar fossa in a modern cohort likely to have been treated with intensity-modulated radiation therapy, chemotherapy for stage III and IV, and have had a high incidence of human papillomavirus-associated tumors. STUDY DESIGN/METHODS:Retrospective cohort analysis utilizing data from the Surveillance, Epidemiology, and End Results program of patients with base of tongue and tonsillar fossa squamous cell carcinoma from 2004 to 2011. METHODS:The cohort included 15,299 primary base of tongue and tonsillar fossa squamous cell carcinoma patients without distant metastases treated between 2004 and 2011. Subsite differences in overall survival and disease-specific survival were examined with Kaplan-Meier curves. Multivariate cox proportional hazard ratios were estimated for overall and disease-specific survival. RESULTS:The cohort included 7,220 (47.2%) base of tongue and 8,079 (52.8%) tonsillar fossa squamous cell carcinoma patients. Overall survival with all stages combined favored tonsillar fossa (P < .001) and remained superior when stratified by stage. In multivariate analyses adjusted for age, gender, race, and treatment, the hazard ratio for overall survival was superior for tonsillar fossa tumors compared to base of tongue tumors for all stages (stage 1, P = .041; stage 2, P = .006; stages 3 and 4, P < .001). Disease-specific survival also favored improved outcomes for tonsillar fossa. CONCLUSIONS:In this large modern cohort, overall and disease-specific survival favored outcomes in tonsillar fossa compared with base of tongue. Further study is required to evaluate factors that influence survival differences between tonsillar fossa and base of tongue despite modern therapy. LEVEL OF EVIDENCE/METHODS:4 Laryngoscope, 127:1087-1092, 2017.
PMID: 27808409
ISSN: 1531-4995
CID: 3093182

Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation

Platek, Alexis J; Jayaprakash, Vijayvel; Merzianu, Mihai; Platek, Mary E; Cohan, David M; Hicks, Wesley L; Marimuthu, Sathiya P; Winslow, Timothy B; Gupta, Vishal; Arshad, Hassan; Kuriakose, Moni A; Dibaj, Shiva; Marshall, James R; Reid, Mary E; Warren, Graham W; Singh, Anurag K
OBJECTIVES/HYPOTHESIS/OBJECTIVE:The effect of smoking and human papillomavirus (HPV) on overall survival (OS) of oropharyngeal squamous cell carcinoma (OPSCC) patients undergoing concurrent chemotherapy (CCRT) remains unclear. STUDY DESIGN/METHODS:Retrospective review. METHODS:Clinical characteristics of OPSCC patients treated between 2008 and 2015 with CCRT were abstracted from medical records. OS curves and multivariate cox proportional hazard ratios (HRs) were examined. RESULTS:tumors (HR = 6.80, 95% CI = 1.11-41.67) had increased mortality compared to never/former smokers. CONCLUSIONS:patients, respectively. Regardless of pack years and HPV status, efforts should be made to achieve smoking cessation before CCRT. LEVEL OF EVIDENCE/METHODS:4. Laryngoscope, 126:2733-2738, 2016.
PMCID:5880216
PMID: 27346612
ISSN: 1531-4995
CID: 3105742

Free Open Source REDCap Software to Track EORTC QLQ-30 and H&N-35 Quality of Life Scores and Allow Real-Time Clinical Management of Individual Patients [Meeting Abstract]

Platek, A; Ostrowski, A; Platek, M; Beattie, A; Fung-Kee-Fung, S; Gupta, V; Cohan, D; Hicks, W; Arshad, H; Kuriakose, MA; Singh, AK
ISI:000371581900151
ISSN: 1879-355x
CID: 2056912

Oncologic and functional outcome of the preserved eye in malignant sinonasal tumors

Rajapurkar, Mayuri; Thankappan, Krishnakumar; Sampathirao, Leela Mohan C S; Kuriakose, Moni Abraham; Iyer, Subramania
BACKGROUND: The purpose of this study was to analyze the oncologic and functional outcomes of the preserved eye in malignant sinonasal tumors with orbital involvement. METHODS: In a retrospective study of 19 consecutive patients who underwent craniofacial resection or maxillectomy with preservation of orbital contents and adjuvant radiotherapy, the oncological outcome in terms of local recurrence and survival was analyzed. The functional outcome in the preserved eye was analyzed for the cases that did not recur in the orbit. RESULTS: Nineteen patients were analyzed for their oncologic and functional outcomes. Fifteen patients underwent immediate reconstruction of the orbital support. Eight patients had local recurrences; 11 patients were disease free at the end of the follow-up. Squamous cell carcinoma has a high propensity for local recurrences (ie, 5 of 8 local recurrences were squamous cell carcinoma). Sixteen patients, in whom a satisfactory orbital tumor clearance was obtained, remained recurrence free in the orbit. All the preserved eyes retained adequate function after adjuvant radiotherapy. CONCLUSIONS: Adequate local control with preserved visual function can be obtained with surgery and adjuvant radiation in appropriately selected malignant sinonasal tumors with orbital involvement. The preserved eye, if reconstructed appropriately, maintains good overall function with acceptable morbidity.
PMID: 22972502
ISSN: 1043-3074
CID: 831672

Vascular priming enhances chemotherapeutic efficacy against head and neck cancer

Folaron, Margaret; Kalmuk, James; Lockwood, Jaimee; Frangou, Costakis; Vokes, Jordan; Turowski, Steven G; Merzianu, Mihai; Rigual, Nestor R; Sullivan-Nasca, Maureen; Kuriakose, Moni A; Hicks, Wesley L Jr; Singh, Anurag K; Seshadri, Mukund
PURPOSE: The need to improve chemotherapeutic efficacy against head and neck squamous cell carcinomas (HNSCC) is well recognized. In this study, we investigated the potential of targeting the established tumor vasculature in combination with chemotherapy in head and neck cancer. METHODS: Experimental studies were carried out in multiple human HNSCC xenograft models to examine the activity of the vascular disrupting agent (VDA) 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in combination with chemotherapy. Multimodality imaging (magnetic resonance imaging, bioluminescence) in conjunction with drug delivery assessment (fluorescence microscopy), histopathology and microarray analysis was performed to characterize tumor response to therapy. Long-term treatment outcome was assessed using clinically-relevant end points of efficacy. RESULTS: Pretreatment of tumors with VDA prior to administration of chemotherapy increased intratumoral drug delivery and treatment efficacy. Enhancement of therapeutic efficacy was dependent on the dose and duration of VDA treatment but was independent of the chemotherapeutic agent evaluated. Combination treatment resulted in increased tumor cell kill and improvement in progression-free survival and overall survival in both ectopic and orthotopic HNSCC models. CONCLUSION: Our results show that preconditioning of the tumor microenvironment with an antivascular agent primes the tumor vasculature and results in enhancement of chemotherapeutic delivery and efficacy in vivo. Further investigation into the activity of antivascular agents in combination with chemotherapy against HNSCC is warranted.
PMCID:3772633
PMID: 23890930
ISSN: 1368-8375
CID: 831902

Sentinel node biopsy in lieu of neck dissection for staging oral cancer

Rigual, Nestor; Loree, Thom; Frustino, Jennifer; Jayaprakash, Vijayvel; Cohan, David; Sullivan, Maureen; Kuriakose, M Abraham
IMPORTANCE: Neck dissection is the standard staging procedure to ascertain the pathologic status of cervical lymph nodes in patients with oral cavity squamous cell carcinoma (OSCC), but it results in multiple morbidities. OBJECTIVE: To examine outcomes of patients with OSCC who underwent sentinel node biopsy (SNB) as the sole neck staging procedure. DESIGN: Retrospective review of patients who underwent SNB during the period 2005 through 2011. SETTING: National Cancer Institute-designated comprehensive cancer center. PARTICIPANTS: Thirty-eight patients with clinically T1 or T2N0 OSCC. INTERVENTIONS: Preoperative lymphoscintigraphy with intraoperative gamma probe localization was used. Sentinel lymph nodes were serially sectioned, formalin fixed, and examined at 3 levels. All patients with positive SNB results underwent neck dissection, and the patients with negative SNB results were observed clinically. MAIN OUTCOMES AND MEASURES: Sensitivity and predictive value of SNB, recurrence rates, and disease-specific survival rates. RESULTS: There were 18 T1 and 20 T2 tumors. Five patients had positive SNB results, of whom 3 had additional positive nodes on subsequent neck dissection. Two of 33 patients with negative SNB results developed a regional recurrence. The sensitivity and negative predictive value for staging the neck with SNB alone were 71% (5 of 7) and 94% (31 of 33), respectively. Mean follow-up was 31 months. The mean disease-free survival duration for patients with positive and negative SNB results was 30 and 65 months, respectively (P = .08). The disease-specific survival rate for patients with positive and negative SNB results was 80% and 91%, respectively. There was no significant difference in disease-specific survival between patients with true-negative and false-negative SNB results (34 vs 44 months; P = .38). CONCLUSIONS AND RELEVANCE: The majority of patients with positive results on SNB had additional positive nodes on neck dissection. A low rate of isolated neck recurrence was found in patients with negative results on SNB. Individuals with negative results on SNB exhibited better overall and disease-specific survival than those with positive results.
PMID: 23868306
ISSN: 2168-6181
CID: 831982

Nerve-sparing subcapsular resection of head and neck schwannomas: technique evaluation and literature review

Battoo, A J; Sheikh, Z A; Thankappan, K; Hicks, W Jr; Iyer, S; Kuriakose, M A
BACKGROUND: The head and neck region harbours crucial structures and hence the surgical technique used to remove schwannomas from this region should cause minimal damage to these structures, with complete removal of pathology. METHODS: This study entailed a retrospective analysis of 10 patients with head and neck schwannomas that were excised using a nerve-sparing subcapsular dissection technique. The primary aims were to assess the functional impact of the surgical technique on the structure of origin and to evaluate local control. RESULTS: One patient with parapharyngeal schwannoma developed symptoms suggestive of 'first bite syndrome' in the late post-operative period. Another patient with facial nerve schwannoma had House-Brackmann grade II weakness in the immediate post-operative period, which subsequently resolved. None of the patients developed recurrence during a median follow-up period of two years. CONCLUSION: The nerve-sparing subcapsular dissection technique provided effective local control of tumour pathology, with relative preservation of neural function post-operatively.
PMID: 23732042
ISSN: 0022-2151
CID: 831992